Talphera, Inc. (TLPH)
1.21
-0.04
(-3.20%)
USD |
NASDAQ |
Dec 11, 16:00
1.21
0.00 (0.00%)
After-Hours: 19:38
Talphera Research and Development Expense (Quarterly): 1.803M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| CorMedix, Inc. | 5.098M |
| Microbot Medical, Inc. | 1.161M |
| Aethlon Medical, Inc. | 0.2943M |
| Iovance Biotherapeutics, Inc. | 75.17M |
| Beyond Air, Inc. | 2.45M |